1. Aratana Therapeutics Announces Additions to Board of Directors

    Aratana Therapeutics Announces Additions to Board of Directors

    KANSAS CITY, Kan., Feb. 5, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX)  a pet therapeutics company focused on the licensing or acquisition, development and commercialization of innovative biopharmaceutical products for cats, dogs and other companion animals, today announced additions to its Board of Directors... 

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. Steven St. Peter, M.D., President and Chief Executive Officer of Aratana Therapeutics, stated.
  3. Topics Mentioned